A political battle is brewing on Capitol Hill with an unlikely source: a weed killer.
Congress is demanding to know why the Environmental Protection Agency posted and then pulled a long-awaited report on the carcinogenicity of glyphosate, the world’s most widely used herbicide. The weed killer is also the latest bogeyman for anti-GMO activists.
Two congressional committees — the House Committee on Science, Space and Technology and the House Agriculture Committee — have asked EPA Administrator Gina McCarthy to explain why her agency took the assessment offline and is continuing to delay its release.
On April 29, the EPA posted a report concluding that glyphosate (the active ingredient in Roundup herbicide and other products) is “not likely to be carcinogenic.” The committee found no relationship between glyphosate exposure and a number of cancers, including leukemia, multiple myeloma, and Hodgkin lymphoma. The 86-page assessment was signed by the EPA’s cancer review committee back in October 2015 and marked “final.”
But the EPA took it down on May 2, claiming the documents were “inadvertently” posted and only a preliminary report. “EPA has not completed our cancer review. We will look at the work of other governments. . . . our assessment will be peer reviewed and completed by end of 2016,” said an EPA spokeswoman.
That move caught the attention of House Science Committee chairman Lamar Smith (R., Texas), who fired off a letter two days later to McCarthy, questioning the agency’s “apparent mishandling” of the report and demanding all documents and communications about the report dating back to January 1, 2015. The House Agriculture Committee followed up with its own letter (signed by both the chairman and the ranking member) asking McCarthy why the agency has “continually delayed its review of glyphosate.” Both committees expect answers within the coming weeks.